Surrozen (SRZN) EBIT Margin (2020 - 2026)
Surrozen's EBIT Margin was -207.40% in Q2 2026, up 709.89 percentage points from -917.29% a year earlier and up 1.72 percentage points from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) EBIT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Surrozen's EBIT Margin was -385.28% through Jun 30, 2026, down 179.85 percentage points year-over-year; for FY2025, it came in at -1210.58%, down 970.89 percentage points from FY2024.
- EBIT Margin shows a three-year change of -855.87 percentage points (FY2022 to FY2025).
- In earlier years, EBIT Margin was -239.69% in FY2024 and -354.71% in FY2022.
- The Q2 2026 figure marks the highest quarterly EBIT Margin since Q3 2024.
- Compared with a year earlier, EBIT Margin was higher in two of the last four quarters, with an average year-over-year change of -182.31 percentage points.
- Per Business Quant data, SRZN's EBIT Margin in the three quarters before Q2 2026 was -209.12% (Q1 2026), -2393.75% (Q4 2025) and -1107.32% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Surrozen | 389.19 Mn | 9.67 Mn | - | -207.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -207.40% |
| Mar 31, 2026 | -209.12% |
| Dec 31, 2025 | -2,393.75% |
| Sep 30, 2025 | -1,107.32% |
| Jun 30, 2025 | -917.29% |
| Mar 31, 2025 | -971.62% |
| Dec 31, 2024 | -1,311.76% |
| Sep 30, 2024 | 12.32% |
| Sep 30, 2021 | -97,892.86% |
| Sep 30, 2020 | -144,016.67% |
API Access
Surrozen EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();